Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry L Luchsinger

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2026
Inflammasome adaptor protein ASC is a mechanistic checkpoint in IL-1β maturationGiti Saha, Pratibha Anchi, Richard Wang, et al.
Cell Reports. Medicine|November 1, 2023
Insights into highly engraftable hematopoietic cells from 27-year cryopreserved umbilical cord bloodHal E Broxmeyer, Larry L Luchsinger, Rona Singer Weinberg, et al.
BMC Infectious Diseases|August 26, 2021
Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formatsDaniel J Nesbitt, Daniel P Jin, Joseph W Hogan, et al.
Cell Reports|December 24, 2016
Anabolism-Associated Mitochondrial Stasis Driving Lymphocyte Differentiation over Self-RenewalWilliam C Adams, Yen-Hua Chen, Radomir Kratchmarov, et al.
Plos One|April 28, 2021
Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening"Daniel K Jin, Daniel J Nesbitt, Jenny Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 PatientsLarry L Luchsinger, Brett Ransegnola, Daniel Jin, et al.
Journal of Clinical Microbiology|September 12, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 PatientsLarry L Luchsinger, Brett P Ransegnola, Daniel K Jin, et al.
Nature|March 18, 2021
The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesisTrevor P Fidler, Chenyi Xue, Mustafa Yalcinkaya, et al.
Communications Biology|November 23, 2021
High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19Winston A Haynes, Kathy Kamath, Joel Bozekowski, et al.
Cell Stem Cell|December 5, 2017
Bone Marrow Myeloid Cells Regulate Myeloid-Biased Hematopoietic Stem Cells via a Histamine-Dependent Feedback LoopXiaowei Chen, Huan Deng, Michael J Churchill, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2026
Inflammasome adaptor protein ASC is a mechanistic checkpoint in IL-1β maturationGiti Saha, Pratibha Anchi, Richard Wang, et al.
Cell Reports. Medicine|November 1, 2023
Insights into highly engraftable hematopoietic cells from 27-year cryopreserved umbilical cord bloodHal E Broxmeyer, Larry L Luchsinger, Rona Singer Weinberg, et al.
BMC Infectious Diseases|August 26, 2021
Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formatsDaniel J Nesbitt, Daniel P Jin, Joseph W Hogan, et al.
Cell Reports|December 24, 2016
Anabolism-Associated Mitochondrial Stasis Driving Lymphocyte Differentiation over Self-RenewalWilliam C Adams, Yen-Hua Chen, Radomir Kratchmarov, et al.
Plos One|April 28, 2021
Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening"Daniel K Jin, Daniel J Nesbitt, Jenny Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 PatientsLarry L Luchsinger, Brett Ransegnola, Daniel Jin, et al.
Journal of Clinical Microbiology|September 12, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 PatientsLarry L Luchsinger, Brett P Ransegnola, Daniel K Jin, et al.
Nature|March 18, 2021
The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesisTrevor P Fidler, Chenyi Xue, Mustafa Yalcinkaya, et al.
Communications Biology|November 23, 2021
High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19Winston A Haynes, Kathy Kamath, Joel Bozekowski, et al.
Cell Stem Cell|December 5, 2017
Bone Marrow Myeloid Cells Regulate Myeloid-Biased Hematopoietic Stem Cells via a Histamine-Dependent Feedback LoopXiaowei Chen, Huan Deng, Michael J Churchill, et al.
Pageof 2